Home | Life Sciences Intellectual Property Review
Nov 7, 2024 · Dexcom suffers second patent revocation at hands of UPC. The court rejected the medical device company’s auxiliary requests and nixed patent in 17 territories although it …
Latest News & Features | Life Sciences Intellectual Property Review
Nov 5, 2024 · A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | Case stemmed from a previous arbitration …
Americas | Life Sciences Intellectual Property Review
13 February 2024 US Patent and Trademark Office publishes ‘clear’ guidance mandating AI-related patents to have ‘significant’ human involvement | Cites one hypothetical example …
‘We took Ravgen head-on’: How we won zero-damages and …
10 hours ago · Michael Summersgill and his co-counsel at WilmerHale secured more favourable outcomes for their clients than others in a series of lawsuits brought by Ravgen over pre-natal …
Big Pharma | Life Sciences Intellectual Property Review
2024 forecast: AI, patent eligibility and Fintiv. Life science attorneys should see some notable developments relating to artificial intelligence, patent eligibility and the Fintiv rule, write Manita …
CRISPR | Life Sciences Intellectual Property Review
9 November 2020 The European Patent Office has released the long-awaited reasoning for its decision to uphold the revocation of a Broad Institute CRISPR/Cas9 patent. In January this …
Biotechnology | Life Sciences Intellectual Property Review
5 November 2024 A jury in Delaware unanimously dismissed all allegations of misappropriation against Inhibrx, a Sanofi-owned biotech firm | Case stemmed from a previous arbitration …
‘This is a big problem’: The CRISPR controversy and the ‘mess’ at …
Sep 27, 2024 · A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain …
The future of precision medicine part 1: challenges and …
Jun 13, 2018 · The promise of precision medicine has been extolled by researchers and clinicians for some time, but as sequencing costs continue to fall, sophistication of data analysis and …
EPO’s new examination guidelines: what you need to know
Apr 6, 2021 · A new edition of the European Patent Office (EPO) Guidelines for Examination came into force on March 1, 2021. Relevant to life sciences, this edition includes a new …